Alexander Reichard, MD
Adult Reconstructive Orthopaedic Surgery · Spokane, WANPI 1174781421
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $40,950 of the $49,266 with a category attached, or 83.1%. Medical Device Business Services, Inc. accounts for 91.2% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $27,311 and has fallen 96.9% since, to $858 in 2025.
Across 72 payments — averaging $684.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$45K
- Johnson & Johnson$4K
- Davol Inc.$114
- Heron Therapeutics, Inc.$89
What the payments were for
- Consulting fees$40,95083%
- Travel & lodging$5,62911%
- Food & beverage$2,6875%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 38 | $44,914 |
| Johnson & Johnson(2 entities) | 31 | $4,148 |
| Davol Inc. | 2 | $114 |
| Heron Therapeutics, Inc. | 1 | $89 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few adult reconstructive orthopaedic surgery providers in Washingtonto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 29 | $14,164 |
| Celecoxib | 91 | $2,167 |
| Oxycodone Hcl | 276 | $2,002 |
| Amoxicillin | 428 | $954 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 81 | $758 |
| Cephalexin | 204 | $541 |
| Ondansetron Hcl | 111 | $375 |
| Hydroxyzine Pamoate | 26 | $193 |
| Clindamycin Hcl | 69 | $191 |
| Meloxicam | 32 | $162 |
| Hydromorphone Hcl | 13 | $118 |
| Pregabalin | 34 | $115 |
| Tramadol Hcl | 22 | $99 |
| Tamsulosin Hcl | 33 | $65 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $4,148 | $14,16429 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few adult reconstructive orthopaedic surgery providers in Washingtonon file to place this against a meaningful peer group, so we don't.
Other adult reconstructive orthopaedic surgery in Spokane
- David ScottSpokane$671K
- Jason HsuSeattle$287K
- Aric ChristalEdmonds$220K
- Nicholas HernandezSeattle$32K
- Cameron EganSeattle$17K
- Jacob StanfieldRichland$14K
- Joseph DannenbaumTacoma$12K
- Patrick MaherKirkland$10K
- Ronald QuamEverett$7K
- Elyse BrinkmannSeattle$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.